$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
TAF的副作用及处理
2025-10-19 11:44:20
Check Details
韦立得副作用要怎么处理呢?
2025-10-19 11:44:20
Check Details
韦立得的副作用怎么应对?
2025-10-19 11:44:20
Check Details
服用TAF可能产生什么副作用?
2025-10-19 11:44:20
Check Details
韦立得的不良反应应对策略
2025-10-19 11:44:20
Check Details
韦立得会产生什么副作用?
2025-10-19 11:44:20
Check Details
韦立得的最常见副作用
2025-10-19 11:44:20
Check Details
用韦立得可能产生严重副作用吗?
2025-10-19 11:44:20
Check Details
富马酸替诺福韦二吡呋酯片副作用是什么?怎么处理?
2025-10-19 11:44:20
Check Details
富马酸替诺福韦二吡呋酯片常见副作用有什么呢?
2025-10-19 11:44:20
Check Details
替诺福韦艾拉酚胺的副作用有什么?
2025-10-19 11:44:20
Check Details
TAF的副作用是什么?怎么处理?
2025-10-19 11:44:20
Check Details
1
2
...
5817
5818
5819
5820
5821
5822
5823
...
10242
10243
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Klygefa FDA Approval: Weekly Subcutaneous C5 Inhibition for AChR-Positive gMG
2
What Is Pralsetinib? RET-Positive Lung and Thyroid Cancer Explained
3
Sotorasib Diarrhea in NSCLC: Grading, Loperamide and Dose Adjustment
4
Avatrombopag vs Eltrombopag in ITP: Onset, Dosing Rules and Pre‑Procedure Use
5
Gilteritinib and Differentiation Syndrome in AML: Recognition, Emergency Management and Monitoring
6
Pralsetinib and Hypertension in NSCLC: Risks, Monitoring and Management
7
Tucatinib Overview: HER2-Positive Breast Cancer and RAS Wild-Type Colorectal Cancer Dosing, Brain Metastases Data and Safety
8
FDA Approves Durvalumab Plus Enfortumab Vedotin for Perioperative Treatment of Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
9
Bepirovirsen (Hibsago) Prescribing Information: Indications, Boxed Warnings, Dose Adjustment and Monitoring
10
Avapritinib (Ayvakit) Prescribing Information: Indications, Dosage, Adverse Reactions and Safety Warnings
11
Daraxonrasib Pregnancy, Lactation and Contraception Safety
12
Afatinib Side Effects and Safety Management